{"id":"NCT00174915","sponsor":"Takeda","briefTitle":"Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.","officialTitle":"A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-02","primaryCompletion":"2004-04","completion":"2004-04","firstPosted":"2005-09-15","resultsPosted":"2009-07-16","lastUpdate":"2012-02-02"},"enrollment":1072,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Gout"],"interventions":[{"type":"DRUG","name":"Febuxostat","otherNames":["TMX-67","Tei-6720","Uloric"]},{"type":"DRUG","name":"Febuxostat","otherNames":["TMX-67","Tei-6720","Uloric"]},{"type":"DRUG","name":"Febuxostat","otherNames":["TMX-67","Tei-6720","Uloric"]},{"type":"DRUG","name":"Allopurinol","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Febuxostat 80 mg QD","type":"EXPERIMENTAL"},{"label":"Febuxostat 120 mg QD","type":"EXPERIMENTAL"},{"label":"Febuxostat 240 mg QD","type":"EXPERIMENTAL"},{"label":"Allopurinol QD","type":"ACTIVE_COMPARATOR"},{"label":"Placebo QD","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to compare febuxostat, allopurinol and placebo, once daily (QD), in subjects with gout.","primaryOutcome":{"measure":"Percentage of Subjects Whose Last Three Serum Urate Levels Are <6.0 Milligram Per Deciliter (mg/dL).","timeFrame":"Last 3 visits (any last 3 visits up to week 28)","effectByArm":[{"arm":"Febuxostat 80 mg QD","deltaMin":48,"sd":null},{"arm":"Febuxostat 120 mg QD","deltaMin":65,"sd":null},{"arm":"Febuxostat 240 mg QD","deltaMin":69,"sd":null},{"arm":"Allopurinol QD","deltaMin":22,"sd":null},{"arm":"Placebo QD","deltaMin":0,"sd":null}],"pValues":[{"comp":"OG000 vs OG004","p":"<0.001"},{"comp":"OG001 vs OG004","p":"<0.001"},{"comp":"OG002 vs OG004","p":"<0.001"},{"comp":"OG000 vs OG003","p":null},{"comp":"OG001 vs OG003","p":null},{"comp":"OG000 vs OG003","p":"<0.001"},{"comp":"OG001 vs OG003","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG002 vs OG003","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"0.479"},{"comp":"OG003 vs OG004","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["18975369","18600509","21353107","22052584"],"seeAlso":["http://general.takedapharm.com/content/file.aspx?applicationcode=6C7C39D8-5D09-453B-BF30-696A4AB88E62&fileTypeCode=ULORICPI"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":267},"commonTop":["Upper Respiratory Tract Infections","Musculoskeletal and Connective Tissues Signs and Symptoms NEC","Diarrhoea (Excluding Infective)","Joint Related Signs and Symptoms","Headache NEC"]}}